Navigation Links
DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Release of Latest Case Management Order in New Jersey DePuy ASR Recall Litigation
Date:8/26/2013

New York, New York (PRWEB) August 26, 2013

Hundreds of DePuy ASR hip lawsuits (http://www.depuy-asr-hip-recall.com/) that are part of a consolidated docket in New Jersey Superior Court, Bergen County, continue to move forward, Bernstein Liebhard LLP reports. On August 21, 2013, the Court issued a Case Management Order that addressed a number of issues, including the progress of discovery and preparations for the DePuy ASR recall litigation’s first bellwether trial, which is scheduled to begin on October 21, 2013. Court records indicate that more than 650 DePuy ASR lawsuits are currently pending in the New Jersey proceeding. (In Re DePuy ASR Hip Implants Litigation, BER-L-3971-11)

"Even though the DePuy ASR recall occurred three years ago, our firm hears from recipients of this device on a regular basis who suffered painful complications, allegedly due to the metal debris shed from its metal-on-metal components,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including hundreds of clients in DePuy ASR lawsuits. The Firm continues to offer free legal evaluations to anyone who suffered serious complications associated with the DePuy ASR recall.

DePuy ASR Recall
According to the U.S. Food & Drug Administration (FDA), the DePuy ASR recall was announced in August 2010 after data revealed that 13% of patients who received the metal-on-metal hip implants needed to have a second surgery to replace the device. Since then, court documents indicate that some 11,500 DePuy ASR lawsuits have been filed in courts around the country, all of which allege metal debris shed from the hip replacements can build to dangerous levels in the body, resulting in metallosis, premature device failure and other serious complications that may necessitate revision surgery.

In addition to the claims pending in the New Jersey proceeding, more than 7,800 DePuy ASR lawsuits involving similar allegations have been filed in a federal multidistrict litigation underway in U.S. District Court, Northern District of Ohio. Bernstein Liebhard LLP is actively filing claims in this litigation. Its first trial is expected to begin on September 9, 2013. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

On the state court level, two DePuy ASR recall claims have already gone to trial. In March, a plaintiff was awarded more than $8 million after a Los Angeles Superior Court jury found that the hip implant was defectively designed. (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County) However, a jury in Chicago found for Johnson & Johnson in a second trial just one month later. (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County)

Hip replacement recipients who suffered metallosis, premature device failure or other complications allegedly associated with the DePuy ASR recall may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. Read more about DePuy ASR lawsuits at Bernstein Liebhard LLP’s website. For a free case review, please contact one of our attorneys by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.depuy-asr-hip-recall.com/

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-asr-recall/prweb11061505.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Pinnacle Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal Pinnacle Hip Litigation
2. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Latest Defense Motion in Federal DePuy ASR Recall Litigation
3. DePuy ASR Lawsuit Update: Rottenstein Law Group LLP Responds to J&J $3 Billion Settlement Report
4. Possible August 2013 Deadline Ahead for North Carolina DePuy ASR Hip Recall Lawsuits, Product Liability Lawyer Ben Cochran Says
5. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Most Recent Developments in New Jersey DePuy ASR Recall Litigation
6. Plaintiff Furnishes Witness List for First Trial in DePuy ASR Multidistrict Litigation, Reports Parker Waichman LLP
7. US Drug Watchdog Urges Recalled DePuy ASR Hip Implant Recipients To Call Them Immediately If They Live In A State Where The Statute Of Limitations Has Not Yet Run Out
8. New DePuy Metal Hip Implant Lawsuits Allegations Update: Resource4thePeople Reports Important Trial Scheduled in Federal Consolidated Cases
9. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes New Pre-trial Ruling in Federal DePuy ASR Recall Litigation
10. DePuy ASR Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Release of New Pretrial Order in New Jersey DePuy ASR Recall Litigation
11. DePuy ASR Lawsuit News: Rottenstein Law Group LLP Comments on Judge’s Decision to Exclude 2010 ASR Recall from Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... ... LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport solutions ... definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner Transportation ...
(Date:8/18/2017)... ... August 18, 2017 , ... As an ... an educational webinar, they will present the line of epMotion automated liquid handling ... easy you can automate everyday pipetting tasks. , Ideal for scientists and lab ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a Houston ... east Texas, is launching a regional charity effort to provide publicity assistance and ... Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations that ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Golseth Agency, a Texas based ... area, is spearheading a regional charity campaign organized to provide support to Christina Upchurch ... of this year, Christina and her children returned from out of town to find ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the ... efforts with its product now available through Jet.com. , After 25 years of ... powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... 15, 2017 AccuGenomics, Inc., a diagnostic company ... announced that the company has provided an AccuKit to ... Carolina at Chapel Hill and to Qura Therapeutics for ... and quantify HIV reservoir and viral expression in human ... HIV Cure Center is a joint initiative between the ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: